Drugs company Indivior has announced its plans to acquire Nasdaq-listed Opiant Pharmaceuticals. The latter business is developing treatments for addiction and drug overdose.
Indivior to acquire Opiant Pharmaceuticals
Share
Join our network of executives who receive the MBS News daily, as well as the insights, analysis and our weekly column in The Weekend Edition.
You’ll be able to unsubscribe at any time.